![New responsibilities for aged kinases in B‐lymphomas - Piazza - 2020 - Hematological Oncology - Wiley Online Library New responsibilities for aged kinases in B‐lymphomas - Piazza - 2020 - Hematological Oncology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a85bd41d-cc07-4579-9bf1-8267b5a6052b/hon.v38.1.cover.jpg)
New responsibilities for aged kinases in B‐lymphomas - Piazza - 2020 - Hematological Oncology - Wiley Online Library
![Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/03ea64b3-8bc1-4956-a1fb-634144317b3c/gr1.jpg)
Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology
![New responsibilities for aged kinases in B‐lymphomas - Piazza - 2020 - Hematological Oncology - Wiley Online Library New responsibilities for aged kinases in B‐lymphomas - Piazza - 2020 - Hematological Oncology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7fb61870-7b4b-49c7-bc4d-67e7d30dcc44/hon2694-fig-0001-m.jpg)
New responsibilities for aged kinases in B‐lymphomas - Piazza - 2020 - Hematological Oncology - Wiley Online Library
Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry
![Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-012-0286-9/MediaObjects/12032_2012_286_Fig1_HTML.gif)